APA (7th ed.) Citation

G, B., M, B., S, C., M, I., R, C., V, A., . . . C, C. (2022). Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019-2021): Emergence of complex resistance phenotypes. Journal of chemotherapy (Florence, Italy), 34(5), 302. https://doi.org/10.1080/1120009X.2022.2031471

Chicago Style (17th ed.) Citation

G, Bianco, et al. "Activity of Ceftolozane-tazobactam, Ceftazidime-avibactam, Meropenem-vaborbactam, Cefiderocol and Comparators Against Gram-negative Organisms Causing Bloodstream Infections in Northern Italy (2019-2021): Emergence of Complex Resistance Phenotypes." Journal of Chemotherapy (Florence, Italy) 34, no. 5 (2022): 302. https://doi.org/10.1080/1120009X.2022.2031471.

MLA (9th ed.) Citation

G, Bianco, et al. "Activity of Ceftolozane-tazobactam, Ceftazidime-avibactam, Meropenem-vaborbactam, Cefiderocol and Comparators Against Gram-negative Organisms Causing Bloodstream Infections in Northern Italy (2019-2021): Emergence of Complex Resistance Phenotypes." Journal of Chemotherapy (Florence, Italy), vol. 34, no. 5, 2022, p. 302, https://doi.org/10.1080/1120009X.2022.2031471.